PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Retention”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources

Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice.

Sildenafil (1, 3, 10, and 30mg/kg, intraperitoneally (i.p.)), a cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) inhibitor, facilitated retention performance of a one-trial step-through inhibitor avoidance task, when administered to male Swiss mice immediately after training, as indicated by performance on a retention test 48 h later. The dose-response curve was an inverted U in this dose range, although only the dose of 3 mg/kg of sildenafil produced significant effects. Sildenafil did not affect response latencies in mice not given the footshock on the training trial, indicating that the actions of sildenafil on retention were not due to non-specific proactive effects on retention performance. The effects of sildenafil (3 mg/kg, i.p.) were time-dependent, and the administration of sildenafil (3 mg/kg, i.p.) 30 min prior to the retention test did not affect retention in mice given post-training injections of vehicle or sildenafil (3 mg/kg, i.p.). However, the administration of sildenafil (3mg/kg, i.p.) 30 min before training also enhanced retention performace. Further, when mice were trained and received immediate post-training sildenafil (3 mg/kg) and were tested for retention either 1 week or 1 month later, at each retention interval the performance was comparable to that found with a 48-h retention interval. Finally, an enhancement of retention was also observed in female Swiss mice that received sildenafil (3 mg/kg, i.p.) immediately, but not 180min, after training. These findings could indicate that the actions of sildenafil on retention are not sex-dependent. The results suggest that sildenafil influences retention by modulating time-dependent mechanisms involved in memory storage and that the effects are long lasting. A possible participation of the nitric oxide (NO)-guanylyl cyclase-cGMP system also is suggested.

3',5'-Cyclic-GMP Phosphodiesterases↗

Studying the retention of rural physicians.

Rural communities and policy-makers struggle with efforts to enhance the retention of rural physicians. Research available to guide these efforts is often weak methodologically and thus may be pointing retention efforts in nonproductive directions. This article discusses a range of methodologic issues encountered in rural physician retention studies for the purpose of strengthening future studies. Ideal study approaches to answer causal questions, including questions about the "causes" of rural physician retention, must demonstrate good internal validity, for which chance, bias, and confounding are accounted. Retention studies that rely simply on asking physicians why they stay or leave rural areas can be useful at times, but are too prone to bias and their findings difficult to verify. Simply identifying what physicians find satisfying or dissatisfying about rural work also will not reliably reveal why they stay or leave, a related but still distinct question. Stronger approaches to studying retention include the traditional quantitative study--in which retention factors are identified when they are statistically related to physicians' retention, and the increasingly popular qualitative study--in which retention issues are revealed through prolonged, in-depth interactions with physicians. This article also discusses various definitions of retention, the use of survival curves to present retention findings, and the importance of studying retention in inception cohorts. The benefits and downside of studying retention with prospective and retrospective study designs are described.

Career Mobility↗

A comprehensive survey of retention procedures in Australia and New Zealand.

OBJECTIVES: This survey aimed to identify consistencies in retention procedures. METHODS: Three hundred Australian orthodontists and 70 New Zealand orthodontists were randomly selected for the study. A questionnaire gathered their views regarding the most commonly used retainers, wire types and sizes of bonded retainers, factors influencing the design of retainers, duration of regular retention, definition of permanent retention, percentage of cases that needed permanent retention, factors influencing the decision to use permanent retention, changes in retention protocols over the last five years, and reasons for such changes. RESULTS: Upper invisible and lower canine-to-canine bonded retainers were the most commonly used retainers. Pretreatment tooth position was the major factor influencing the design of retainers, and most respondents preferred bonded retainers. The majority preferred multistrand stainless steel wire for bonded retainers. The most common wire size was 0.0175 inch. Orthodontists more commonly recommended a regular retention period of more than two years, and defined permanent retention as "lifetime". Orthodontists applied permanent retention to either a very high or very low percentage of their cases. A high percentage of respondents made changes to their retention protocols over the past five years. There was no relationship between factors influencing the design of retainers and the preferred type of retainer. There was no consensus on the major factor influencing the decision to use permanent retention. CONCLUSIONS: Retention procedures are variable and dependent largely on personal preferences. There does not seem to be any consistent pattern in the application of retention methodologies.

Australia↗

A new temporary catheter (ContiCath) for the treatment of temporary, reversible, postoperative urinary retention.

OBJECTIVES: To describe the initial experience of a newly designed temporary urethral catheter, ContiCath, as an aid in the management of postoperative or temporary outflow obstruction. In patients with normal detrusor and sphincter function, this catheter allows volitional voiding while maintaining an open prostatic urethra. METHODS: In a pilot study, 64 nonconsecutive patients with postoperative or temporary urinary retention, at eight clinical trial sites, were enrolled for the placement of this temporary catheter. Three patients did not have the catheter placed because of placement failure because of either a large median lobe or a urethral stricture. The remaining 61 patients were divided into three groups: those with non-neuropathic causes of retention and retention for 1 week or less (37 patients), those with non-neuropathic causes of retention and retention for longer than 1 week (19 patients), and those with neuropathic causes of retention and retention for longer than 1 week (5 patients). The ContiCath is placed in the office setting, in the same fashion as a Foley catheter. A blue prolene tether extends from the bulbar urethra to the meatus to assist in the removal of the device. Patients were then reassessed at 3 hours, and at 7, 14, 21, and 28 days, at which point the device was removed. RESULTS: In patients with a neuropathic cause for their retention (5 patients) and those with non-neuropathic causes of retention and retention for longer than 1 week (19 patients), only 3 patients were able to void after the catheter was placed. Of the 37 patients with a non-neuropathic cause and retention 1 week or less, controlled voiding was seen in 33 patients (89%). Controlled voiding was defined as the patient's volitional ability to initiate and stop his urinary stream. There were no complications with catheter placement; however, 8 patients (24.2%) had minor adverse experiences of frequency/urgency (n = 3), incontinence (n = 3), migration of the catheter (n = 1), and pain (n = 1). CONCLUSIONS: ContiCath offers an alternative to an indwelling Foley catheter in men with temporary bladder outlet obstruction and urinary retention.

Aged↗

The impairment of retention induced by beta-endorphin in mice may be mediated by a reduction of central cholinergic activity.

beta-Endorphin (0.03 to 1.00 microgram/kg, ip) impaired retention of a one-trial inhibitory avoidance task in a dose-dependent manner when injected into male Swiss mice immediately post-training, as indicated by retention performance 48 h later. The doses of 0.03 and 0.10 microgram/kg significantly impaired retention while the two higher doses (0.30 and 1.00 microgram/kg) did not significantly affect retention as compared with the control group, but tended to increase retention as compared with the dose of 0.10 microgram/kg. Thus, the dose-response curve shows an U-shaped form. The simultaneous injection of naloxone (0.1 mg/kg, ip) not only shifted the dose-response curve to the right but also prevented the tendency to increase retention latencies of the two higher doses. The two lower doses of beta-endorphin did not lengthen latencies to step-through of mice that had not received a footshock during the training while, under these conditions, the two higher doses of the peptide significantly increased latencies to step-through. This effect was prevented by naloxone (0.1 mg/kg). Taken together these results suggest that the effects of beta-endorphin on retention are the consequence of an interaction with opioid receptors and indicate that the right ascending arm of the dose-response curve would probably be due to a punitive effect of beta-endorphin which was also prevented by naloxone. The impairing effect of post-training administration of beta-endorphin (0.10 microgram/kg) on memory was time-dependent, since it was decreased as the training-treatment interval was increased. These results rule out a pharmacological proactive effect of beta-endorphin on retention performance and suggest that beta-endorphin affects memory consolidation. The simultaneous administration of beta-endorphin (0.10 microgram/kg) with the central muscarinic agonist oxotremorine (12.5 or 50.0 micrograms/kg) completely prevented the impairment of retention induced by beta-endorphin, while the simultaneous administration of the central-acting anticholinesterase physostigmine (17 or 68 micrograms/kg) only partially but significantly attenuated the effect of beta-endorphin on retention. Further, the peripheral-acting anticholinesterase neostigmine (68 micrograms/kg) and the nicotinic blocker hexamethonium (5 mg/kg) modified neither retention nor the behavioral effects of beta-endorphin. These results suggest that the impairment of retention induced by beta-endorphin is probably due to an inhibition of acetylcholine release at central cholinergic synapses which are critical for memory formation.

Acetylcholine↗

Retention of endodontic dowels: effects of cement, dowel length, diameter, and design.

The retentive capacity of three preformed endodontic dowel designs was compared at two lengths and two diameters, with three different cements. The greatest single factor influencing retention of these devices was the design used. Of the types tested in this study, the most retentive were threaded, parallel-sided dowels screwed into tapped channels. Serrated, parallel-sided dowels cemented in matched cylindrical channels provided intermediate retention, and smooth-sided tapered posts were the least retentive. Another major factor in retention was the length of imbedment into dentin. An increase in dowel imbedment depth usually corresponded to increased retention. The effect of cement type was significant only with tapered dowels. Zinc phosphate cement was most retentive, carboxylate cement exhibited intermediate retention, and the epoxy cement was least retentive. For the other post designs, cement type had no significant effect on retentive capacity. Finally, variations in dowel diameter had no significant effect on retentive ability.

Crowns↗

Progesterone treatment increases pituitary oestradiol retention in the ovariectomized normal female rat but not in the male nor in the androgen- or oestrogen-sterilized female rat.

Pituitary retention of [3H] oestradiol in ovariectomized rats was measured following in vivo progesterone pre-treatment and found to be significantly increased after 48, 72, 96 and 120 h of pre-treatment. Increased [3H]-oestradiol retention was also observed for at least up to 72 h after removal of the progesterone pre-treatment source. This retention was measured as DPM per mg dry tissue weight. [3H] Oestradiol retention was also measured in the nuclear fraction of tissues incubated with [3H]-oestradiol in vitro. Following 72 h of in vivo progesterone pre-treatment, the nuclear fraction from the pituitary was found to retain significantly more [3H]oestradiol than corresponding fractions from non-treated animals. In contrast to ovariectomized females, no increase in [3H]oestradiol retention was found in the pituitary of orchidectomized males pre-treated with progesterone for 72 h. [3H]Oestradiol retention by pituitaries of ovariectomized rats injected on the day of birth with 200 mug oestradiol benzoate (OeB) or 500 mug testosterone propionate (TP) was significantly decreased in comparison to control animals. When the rats were pre-treated in vivo with oestradiol for 6 or 72 h and [3H]oestradiol retention was measured 6 or 24 h after this pre-treatment, the OeB and TP treated animals retained significantly less [3H]oestradiol under most treatment conditions. Progesterone pre-treatment for 24 or 72 h in vivo followed by measurement of [3H]oestradiol retention immediately or 6 or 24 h later resulted in a significant increase in [3H]oestradiol retention for the control animals. In contrast, the neonatally OeB or TP treated animals differed significantly by not showing increased retention. When [3H]oestradiol retention of the pituitary was measured in vitro following homogenization at 0 degrees C and incubation at 37 degrees C for 1 h, the nuclear fraction from both OeB and TP treated animals was found to retain less hormone per unit DNA; however, this decrease was significant only for the TP animals. Thus, males and androgen- or oestrogen-sterilized females have an altered and reduced augmentation of pituitary oestradiol retention in response to both oestrogen and progesterone pre-treatments.

Animals↗

[Discussion on the concept problem of the specific retention volume in gas chromatography].

The concept problem in the definition of well-known specific retention volume in GC is proposed in this paper. The specific retention volume Vg is usually defined as the net retention volume per gram of liquid phase corrected to 273.15 K in some literatures, and is widely appeared in journals and textbooks as one of the most important absolute retention value in GC, though it is less practical than the relative retention value in the qualitative analysis. Being inspired in the discussion of pressure correction in GC, the author thinks that the temperature correction term in the Vg definition is neither correct nor necessary. The problem was originated from the misunderstanding of the pressure correction of the adjusted retention volume. It is emphasized here that the net retention volume obtained by correction of the adjusted retention volume by compressibility factor j is the retention parameter in term of the column geometrical volume rather than a gas volume. The net retention volume per gram of liquid phase is an absolute retention parameter sufficient to measure the retention power. The author thinks that it is necessary to discuss and clarify the problem to avoid any possible errors being introduced in some cases, such as in the estimation of some thermodynamic parameters.

Artifacts↗

Enhancing retention in clinical trials of psychosocial treatments: practical strategies.

Given the close links between retention and outcome in substance abuse treatment, it is important to recognize that treatments are successful to the degree they retain patients. This chapter described some practical strategies for improving retention in clinical trials of treatment for substance abuse. To summarize: 1. Retention can be conceived as an important treatment outcome that reflects good fit between patient, therapist, treatment, and setting. Procedures and practices that improve the quality of treatment are likely to also improve retention. 2. Attending to the problem of retention may help solve the problem. While trials are ongoing, investigators should monitor retention closely, attending to and addressing variations in retention that might be associated with setting, seasonal variations, therapist factors, and research procedure factors. 3. More data are needed on effective methods of enhancing retention in different treatment settings. It should be noted that the strategies presented here reflect common sense and are for the most part drawn from experience with several clinical trials. Few of them have been evaluated empirically. However, more data on effective retention strategies are likely to have broad clinical and research utility. For example, it would be possible to design studies that evaluate an adaptation of Higgins' voucher system (this volume) to specifically reinforce retention in treatments that have higher rates of attrition, different methods of rewarding clinicians with higher rates of retention, and the effect on retention of adding babysitting services, to mention but some areas where further research would be illuminating.

Clinical Trials as Topic↗

Postoperative urinary retention after surgery for benign anorectal disease: potential risk factors and strategy for prevention.

PURPOSE: This study was undertaken to determine the incidence of and risk factors for urinary retention after surgery for benign anorectal disease. METHODS: We reviewed 2,011 consecutive surgeries performed under spinal anesthesia for benign anorectal disease from January through June 2003 to identify potential risk factors for postoperative urinary retention. In addition, we prospectively investigated the preventive effect of perioperative fluid restriction and pain control by prophylactic analgesics on postoperative urinary retention. RESULTS: The number of procedures and the urinary retention rates were as follows: hemorrhoidectomy, 1,243, 21.9%; fistulectomy, 349, 6.3%; incision/drainage, 177, 2.3%; and sliding skin graft/lateral subcutaneous internal sphincterotomy, 64, 17.2%. The overall urinary retention rate was 16.7%. With hemorrhoidectomy, female sex, presence of preoperative urinary symptoms, diabetes mellitus, need for postoperative analgesics, and more than three hemorrhoids resected were independent risk factors for urinary retention as assessed by multivariate analysis. With fistulectomy, female sex, diabetes mellitus, and intravenous fluids >1,000 ml were independent risk factors for urinary retention. Perioperative fluid restriction, including limiting the administration of intravenous fluids, significantly decreased the incidence of urinary retention (7.9 vs 16.7%, P<0.0001). Furthermore, prophylactic analgesic treatment significantly decreased the incidence of urinary retention (7.9 vs 25.6%, P=0.0005). CONCLUSIONS: Urinary retention is a common complication after anorectal surgery. It is linked to several risk factors, including increased intravenous fluids and postoperative pain. Perioperative fluid restriction and adequate pain relief appear to be effective in preventing urinary retention in a significant number of patients after anorectal surgery.

Adult↗

In vitro retentive strength of zirconium oxide ceramic crowns using different luting agents.

STATEMENT OF PROBLEM: In contrast to gold crowns, in vitro determination of the retentive strength of all-ceramic crowns is more difficult because components allowing connection to testing apparatus are not as easily integrated into the all-ceramic material. Nevertheless, retentive strength data are crucial for obtaining information about the potential clinical performance of luting cements for all-ceramic restorations. Therefore, a new in vitro model was necessary to evaluate the retentive strength of all-ceramic crowns. PURPOSE: The purpose of this in vitro study was to determine the retentive strength of 4 resin-cement systems, a compomer, a glass-ionomer cement, a resin-modified glass-ionomer cement, and a self-adhesive resin for luting zirconium oxide ceramic crowns. MATERIAL AND METHODS: One-hundred-twenty extracted human teeth were randomly divided into 12 groups (n = 10) and prepared in a standardized manner (5-degree taper, 3-mm occlusogingival height). All-ceramic crowns (Lava) were fabricated in a standardized manner for each tooth. The following cements and corresponding bonding regimens were used to lute the crowns to the teeth according to manufacturers' recommendations: CO, Compolute/EBS Multi; CO/RT, Compolute/EBS Multi/Rocatec; CB, Superbond C and B; CB/RT, Superbond C and B/Rocatec; CB/PL, Superbond C&B/Porcelain Liner M; PA, Panavia F; DC, Dyract Cem Plus/Xeno III; CH/PL, Chemiace II/Porcelain Liner M; RL, RelyX Luting, K/C, Ketac Cem/Ketac Conditioner; K, Ketac Cem; and RU, RelyX Unicem. After thermal cycling (5000 cycles, 5 degrees C-55 degrees C), the outer surfaces of the cemented zirconium oxide ceramic crowns were treated (Rocatec) to improve bonding and then placed into a low-shrinkage epoxy resin block (Paladur). The block/crown and tooth components for each specimen were connected to opposing ends of a universal testing machine so that crown retention could be measured. Crowns were removed from teeth along their path of insertion. The retentive surface area (mm 2 ) was determined individually for each tooth. Statistical analyses were performed using the Wilcoxon exact test, (alpha =.05) and a Bonferroni correction (alpha =.001). RESULTS: The median (minimum/maximum) retentive strength values (MPa) were as follows: CO, 1.7 (0.6/4.3); CO/RT, 3.0 (1.3/5.4); CB, 4.8 (3.7/7.9); CB/RT, 8.1 (4.2/12.7); CB/PL, 5.3 (3.7/10.2); PA, 4.0 (3.3/5.1); DC, 3.3 (2.1/5.6); CH/PL, 4.0 (1.3/6.3); RL, 4.7 (2.8/6.6); K/C, 1.8 (0.6/2.3); K, 1.9 (0.2/4.5); and RU, 4.8 (2.5/6.7). Superbond C&B (+ Rocatec) specimens showed the highest median retentive strength, but were not significantly different from Superbond C&B without Rocatec pretreatment of the all-ceramic crown's inner surface. Compolute specimens also did not benefit significantly from the Rocatec pretreatment. Within the materials used without pretreatment of the ceramic, Superbond C&B, Panavia, Dyract Cem Plus, RelyX Luting, and RelyX Unicem showed the highest median retentive strength values and were not significantly different. CONCLUSION: Within the conditions of this study, the compomer-cement, the resin-modified glass-ionomer cement, and the self-adhesive resin luting agent had the same level of retentive quality as the resin luting agents, Superbond C&B, and Panavia. Rocatec pretreatment of the ceramic surface did not improve the retentive strengths of Compolute and Superbond C&B.

Cementation↗

The retention of complete crowns prepared with three different tapers and luted with four different cements.

STATEMENT OF PROBLEM: The role of adhesive properties of cements on the retentive strength of crowns with different degrees of taper is not clear. PURPOSE: This study evaluated the retention of full crowns prepared with 3 different tapers and cemented with 2 conventional and 2 adhesive resin cements. MATERIAL AND METHODS: One hundred twenty sound human molar teeth were assigned randomly to 1 of 12 groups, (n=10). The groups represented the 4 cements: zinc phosphate (Fleck's), a conventional glass ionomer (Ketac-Cem); 2 adhesive resin cements (C&B Metabond and Panavia); and 3 tapers of 6-degrees, 12-degrees, and 24-degrees within each cement. Crowns were cast with a high noble alloy. The 6-degree taper was considered the control within each cement group. Retention was measured (MPa) by separating the metal crowns from the prepared teeth under tension on a universal testing machine. Analysis of variance was used to test the main effects on the retentive strength of full crowns, namely cements, tapers, and failure modes. The Fisher's multiple comparison test was used to evaluate the source of the differences. The chi(2) analyses were used to examine the relationships between failure types, cements, and tapers. All statistical tests were conducted at alpha=.05. RESULTS: There was a significant difference in the main effect cement (P<.0001) and taper (P=.0002). The mean retentive strength values of both Fleck's and Ketac-Cem were significantly lower than the mean retentive strength values of both C&B Metabond and Panavia (P<.0001). The retention of crowns prepared with 6-degree taper was not significant from the 12-degree taper (P=.0666). The difference in retention was significant between the 6-degree taper and the 24-degree taper (P<.0001) and between 12-degree taper and 24-degree taper (P=.0178). The types of failure were adhesive in the cement (65%), cohesive in the tooth (31%), and assembly failure (fracture of embedding resin) (4%). The type of failure was dependent on the degree of taper (P<.0001) and on the type of cement (P<.0042). CONCLUSION: Within the limitations of this study, the retentive values of the adhesive resins at 24-degree taper were 20% higher than the retentive values of the conventional cements at 6-degree taper. The use of resin luting agents yielded retention values that were double the values of zinc phosphate or conventional glass ionomer cement.

Analysis of Variance↗

[Value of PSA/gamma-Sm ratio (P/S ratio) for diagnosis of prostate cancer in patients with urinary retention].

It is known that serum prostate specific antigen (PSA) in urinary retention due to benign prostatic hypertrophy (BPH) increase. To evaluate prognostic value of the ratio of serum PSA to gamma-seminoprotein (P/S Ratio) for prostate cancer (PC) in patients with urinary retention, we have studied the P/S Ratio at the initial examination in 33 patients with untreated PC (10 with and 23 without urinary retention) and 193 patients with untreated BPH (38 with and 155 without urinary retention) histopathologically diagnosed at our hospital between January, 1992 and December, 1993. The results were as follows: 1) The mean P/S ratio of PC patients was significantly higher than that of BPH patients in both groups with and without urinary retention. 2) When the cut off value of P/S Ratio was determined to be 1.35, the highest efficiency, 59.3% was obtained in the group without urinary retention. The sensitivity and specificity were 65.2% and 91.0%. 3) In the group with urinary retention, the efficiency was also the highest, 80.0% with a cut off value of 1.35. The sensitivity and specificity were 80.0% and 100%. 4) In all patients, the efficiency was 64.6%, the sensitivity was 69.7%, and the specificity was 92.7% with a cut off value of 1.35. 5) Positive rate of serum PSA in BPH patients with urinary retention was 47.4% and that in BPH patients without urinary retention was 17.4%. The mean P/S ratio of the BPH patients with urinary retention was significantly lower than that of BPH patients without urinary retention, which suggested that the serum free PSA increase in the former.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

Evaluation of stable retentive properties of overdenture attachments.

OBJECTIVES: To evaluate fatigue of stud (ERA Overdenture (orange and white), Locator Root (pink) and OP anchor # 4) and magnetic (Magfit EX600W) attachments by measuring maximum retentive force. To compare retentive force of overdenture attachments after their reach stable retention. To determine minimum number of cycles required to reach stable retention. MATERIAL AND METHODS: Three specimens of each type of attachment were used. Micromaterial testing machine (MMT-250NB-10, Shimadzu Co., Tokyo, Japan) with a sensor interface PCD-320 and software package PCD-30A (Kyowa Electronic Instruments Co., Tokyo, Japan) was used to performe 2000 insertion-removal cycles with 50 mm/min cross head speed. Maximum retentive force was measured initially and after each 40 cycles. STATISTICAL ANALYSIS: paired-samples t-test, one-way ANOVA and Scheffe post-hoc tests (P<0.05). RESULTS: Before and after fatigue simulation statistically significant differences existed among the five types of attachments. Decrease of retention was characteristic for all attachments except OP. After fatigue LRP was most retentive. Magnetic attachments preserved maximum amount of retention measured at the baseline (98%). EO and EW attachments have preserved only 25% and 37% of initial retention respectively. CONCLUSIONS: Due to fatigue overdenture attachments gradually loose their retention. Stud attachments are more susceptible to fatigue than magnets. Eight hundred cycles are required to achieve relatively stable retention of overdenture attachments.

Dental Abutments↗

Calcium and zinc retention from protein hydrolysate formulas in suckling rhesus monkeys.

OBJECTIVE: To determine calcium and zinc retention from infant formulas based on protein hydrolysates. DESIGN: Randomized, crossover. SETTING: Newborn nursery at the California Primate Research Center, Davis. PARTICIPANTS: Suckling infant rhesus monkeys (N = 7), aged 6 weeks at the beginning of the study. Each infant received seven different formulas. INTERVENTIONS: Fasted infant monkeys were fed diets radiolabeled with calcium 47 and zinc 65. Retention was determined by counting whole body radioactivity immediately after dosing and 7 days after dosing. MEASUREMENTS AND RESULTS: Retention of 47Ca was a mean (+/- SEM) of 79% +/- 4% from casein hydrolysate and 72% +/- 6% from the whey protein hydrolysate formula. Calcium 47 retention from hydrolysates based on whey protein/casein mixtures (a ratio of 60:40 or 50:50) was similar despite differences in protein sources and calcium content. Calcium 47 retention from two types of soy/collagen hydrolysate formula was found to be 68% +/- 6% and 59% +/- 4%, respectively, which is significantly lower than retention from casein hydrolysate. Considering the different calcium content of these formulas, total calcium retention from milk protein hydrolysates was higher than from soy/collagen products. Retention of 65Zn from milk protein hydrolysates ranged from 18% +/- 3% to 29% +/- 4% and was higher than that from soy/collagen formulas with a mean retention of 7% +/- 3% and 10% +/- 4%, respectively. Despite these differences in 65Zn retention, total zinc retention from all soy/collagen formulas was similar due to their higher zinc content. CONCLUSIONS: Calcium and zinc bioavailability was high from formulas based on milk protein hydrolysate, but was considerably lower from soy hydrolysates. Higher levels of calcium and zinc provided in soy hydrolysate formula compensated for the lower bioavailability and resulted in similar amounts of calcium and zinc retained.

Absorption↗

Partitioning of fat and protein in energy retention of growing animals.

With increasing intakes the body fat content increases and that of protein decreases. It is most often assumed that this is brought about because each increment in retention contains more fat and less protein. Experimental results, however, showed that this explanation is not true. In two experiments male broiler chickens were fed at levels between 60 and 100 % of recommended energy intake. Body composition at 1500 g showed, as expected, that with increasing intakes body fat content increased and protein content decreased. Both fat and protein retention per day were linearly related to total energy retention (ER). This means that each increment in retention has the same protein and fat content. At zero fat retention only protein was retained, about 50 % of maximal retention. At zero ER protein was retained and fat mobilized. Energy and N balance experiments confirmed the constant composition of each increment in retention. The results of both experiments show that total ER consisted of two components: a basic constant daily protein retention and a variable additional ER, mainly consisting of fat. The basic protein retention is about half of maximal retention. With increasing energy intakes the basic protein retention is combined with an additional amount of protein and fat in a constant ratio.

Animal Feed↗

Retention of composite inlays in enamel dentin cavities.

The retention of composite inlays depends on acid-etching of marginal enamel of the preparation. In many cases, only little marginal enamel is available, making loss of retention a liability. The present study evaluated the retention of three brands of composite inlays under various conditions. Inlays were fabricated and cemented in standardized enamel/dentin cavities prepared in extracted human teeth. The force necessary to extract a cemented inlay was used to express the retention of the inlay. The effects of thermocycling and choice of dentin-bonding agent on inlay retention were also determined. Inlays made of Estilux posterior C VS were more retentive than inlays of either Brilliant or SR-Isosit. The latter two products were found to provide similar retentive strengths. The retention of Estilux posterior C VS and SR-Isosit inlays declined when samples were thermocycled. Treatment with Gluma increased retention of inlays, resulting in retentive strengths of the same magnitude for all three inlay systems. The choice of dentin-bonding agent was found to affect composite inlay retention to a greater extent than the choice of either composite brand, mode of inlay curing, or effect of thermocycling.

Acid Etching, Dental↗

The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.

OBJECTIVES: The aim of this study was to define the temporal changes in the relationship between technetium-99m teboroxime tissue retention and myocardial blood flow in a canine model. BACKGROUND: Technetium-99m teboroxime is a new neutral lipophilic myocardial perfusion agent. It is known to be highly extracted by the myocardium but to have a rapid clearance rate. METHODS: A wide range of myocardial blood flow was induced in each experiment by regional coronary occlusion and dipyridamole infusion. Myocardial retention of technetium-99m teboroxime was determined by in vitro tissue counting at 1, 2 or 5 min after injection of the tracer. Tracer retention was correlated with microsphere-determined blood flow and the data were fitted to nonlinear functions. RESULTS: Correlation coefficients for these functions were 0.92, 0.95 and 0.95 at 1, 2, and 5 min, respectively. At 1 min after injection, the relationship of technetium-99m teboroxime retention to blood flow was linear over a wide flow range, becoming nonlinear at flow rates greater than 4.5 ml/min per g. After 5 min the retention-flow relationship was linear only to 2.5 ml/min per g, above which little change in retention was noted. Normalized myocardial retention, expressed as a percent of the retention at 1 ml/min per g, was also calculated. At flow rates of 1, 2, 3, 4 and 5 ml/min per g, normalized retention was 100, 169, 228, 277 and 317% at 1 min and 100, 171, 217, 239 and 237% at 5 min after injection. CONCLUSIONS: At 1 min after injection, the relationship of technetium-99m teboroxime myocardial retention to blood flow is well maintained over a wide range of flow. However, after only 5 min, tracer retention underestimates flow changes at moderate and high flow rates. Thus, rapid acquisition protocols are necessary to fully exploit the potential of this promising new tracer in the evaluation of myocardial perfusion.

Animals↗